Prognostic Significance of Circulating Lymphocyte Subsets Before Treatment in Patients with Nasopharyngeal Carcinoma

References

• Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. doi:10.1016/S0140-6736(19)30956-031178151
   PubMed Web of Science ®Google Scholar
• Fu ZT, Guo XL, Zhang SW, et al. [Incidence and mortality of nasopharyngeal carcinoma in China, 2014]. Zhonghua Zhong Liu Za Zhi. 2018;40(8):566–571. Chinese.30139025
   PubMedGoogle Scholar
• Huang CL, Guo R, Li JY, et al. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa. Eur Radiol. 2020;30(2):816–822. doi:10.1007/s00330-019-06500-531650266
   PubMed Web of Science ®Google Scholar
• Wu LR, Zhang XM, Xie XD, Lu Y, Wu JF, He X. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: results from a non-endemic cohort with 10-year follow-up. Oral Oncol. 2019;98:141–146. doi:10.1016/j.oraloncology.2019.09.02931586896
   PubMed Web of Science ®Google Scholar
• Wenbo L, Wang J. Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape. J R Soc Interface. 2017;14:131. doi:10.1098/rsif.2017.0105
   Web of Science ®Google Scholar
• Fridman WH, Zitvogel L, Sautes-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14(12):717–734. doi:10.1038/nrclinonc.2017.10128741618
   PubMed Web of Science ®Google Scholar
• Quigley DA, Kristensen V. Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells. Mol Oncol. 2015;9(10):2054–2062. doi:10.1016/j.molonc.2015.10.00326607741
   PubMed Web of Science ®Google Scholar
• Miller J. The function of the thymus and its impact on modern medicine. Science. 2020;369:6503. doi:10.1126/science.aba2429
   Web of Science ®Google Scholar
• de Pablo R, Monserrat J, Prieto A, Alvarez-Mon M. Role of circulating lymphocytes in patients with sepsis. Biomed Res Int. 2014;2014:671087. doi:10.1155/2014/67108725302303
   PubMed Web of Science ®Google Scholar
• Qin L, Jing X, Qiu Z, et al. Aging of immune system: immune signature from peripheral blood lymphocyte subsets in 1068 healthy adults. Aging. 2016;8(5):848–859. doi:10.18632/aging.10089426886066
   PubMedGoogle Scholar
• Niedźwiedzka-Rystwej P, Tokarz-Deptuła B, Deptuła W. Charakterystyka subpopulacji limfocytów T [Characteristics of T lymphocyte subpopulations]. Postepy Hig Med Dosw. 2013;67:371–379. doi:10.5604/17322693.1048814
   Web of Science ®Google Scholar
• Kurosaki T. B-lymphocyte biology. Immunol Rev. 2010;237(1):5–9. doi:10.1111/j.1600-065X.2010.00946.x20727025
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22(11):633–640. doi:10.1016/S1471-4906(01)02060-911698225
   PubMed Web of Science ®Google Scholar
• Chen M, Jin F, Ma L. The detection and significance of T cells in nasopharyngeal carcinoma patients. J Cancer Res Ther. 2018;14(Supplement):S331–S335. doi:10.4103/0973-1482.23535029970685
   PubMed Web of Science ®Google Scholar
• Tao CJ, Chen YY, Jiang F, et al. A prognostic model combining CD4/CD8 ratio and N stage predicts the risk of distant metastasis for patients with nasopharyngeal carcinoma treated by intensity modulated radiotherapy. Oncotarget. 2016;7(29):46653–46661. doi:10.18632/oncotarget.969527270307
   PubMedGoogle Scholar
• Xu T, Huang Z, Su B, et al. Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinoma. Med Oncol. 2014;31(10):198. doi:10.1007/s12032-014-0198-y25182703
   PubMed Web of Science ®Google Scholar
• Hu FJ, Ge MH, Li P, et al. Unfavorable clinical implications of circulating CD44+ lymphocytes in patients with nasopharyngeal carcinoma undergoing radiochemotherapy. Clin Chim Acta. 2012;413(1–2):213–218. doi:10.1016/j.cca.2011.09.02621983162
   PubMed Web of Science ®Google Scholar
• Lu J, Chen XM, Huang HR, et al. Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma. Head Neck-J Sci Spec. 2018;40(6):1245–1253. doi:10.1002/hed.25104
   PubMed Web of Science ®Google Scholar
• Long G, Tang W, Fu X, et al. Pre-treatment Serum Lactate Dehydrogenase Predicts Distant Metastasis and Poor Survival in Nasopharyngeal Carcinoma. J Cancer. 2019;10(16):3657–3664. doi:10.7150/jca.3271631333783
   PubMed Web of Science ®Google Scholar
• Yang H, Wang K, Liang Z, et al. Prognostic role of pre-treatment serum albumin in patients with nasopharyngeal carcinoma: a meta-analysis and systematic review. Clin Otolaryngol. 2020;45(2):167–176. doi:10.1111/coa.1345431573757
   PubMed Web of Science ®Google Scholar
• Gundog M, Basaran H. The prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in nasopharyngeal cancer. J Buon. 2020;25(1):367–375.32277656
   PubMed Web of Science ®Google Scholar
• Biswas SK. Metabolic Reprogramming of Immune Cells in Cancer Progression. Immunity. 2015;43(3):435–449. doi:10.1016/j.immuni.2015.09.00126377897
   PubMed Web of Science ®Google Scholar
• Chraa D, Naim A, Olive D, Badou A. T lymphocyte subsets in cancer immunity: friends or foes. J Leukoc Biol. 2019;105(2):243–255. doi:10.1002/JLB.MR0318-097R30387907
   PubMed Web of Science ®Google Scholar
• Lakshmi Narendra B, Eshvendar Reddy K, Shantikumar S, Ramakrishna S. Immune system: a double-edged sword in cancer. Inflamm Res. 2013;62(9):823–834. doi:10.1007/s00011-013-0645-923868500
   PubMed Web of Science ®Google Scholar
• Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306. doi:10.1038/nrc324522419253
   PubMed Web of Science ®Google Scholar
• Yang C, Cheng H, Luo G, et al. The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: a new scoring system. Eur j Surgical Oncol. 2017;43(11):2112–2118. doi:10.1016/j.ejso.2017.07.010
   PubMed Web of Science ®Google Scholar
• Cui F, Qu D, Sun R, Nan K. Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy. Med Oncol. 2019;36(10):84. doi:10.1007/s12032-019-1307-831493232
   PubMed Web of Science ®Google Scholar
• Li M, Yao D, Zeng X, et al. Age related human T cell subset evolution and senescence. Immun Ageing. 2019;16:24. doi:10.1186/s12979-019-0165-831528179
   PubMed Web of Science ®Google Scholar
• Kumar BV, Connors TJ, Farber DL. Human T Cell Development, Localization, and Function throughout Life. Immunity. 2018;48(2):202–213. doi:10.1016/j.immuni.2018.01.00729466753
   PubMed Web of Science ®Google Scholar
• Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017;372:1732.
   Web of Science ®Google Scholar
• Liang LB, Huang XY, He H, Liu JY. Prognostic Values of Radiosensitivity Genes and CD19 Status in Gastric Cancer: a Retrospective Study Using TCGA Database. Pharmgenomics Pers Med. 2020;13:365–373. doi:10.2147/PGPM.S26512132982372
   PubMed Web of Science ®Google Scholar
• Pretscher D, Distel LV, Grabenbauer GG, Wittlinger M, Buettner M, Niedobitek G. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. Bmc Cancer. 2009;9:292. doi:10.1186/1471-2407-9-29219698134
   PubMed Web of Science ®Google Scholar
• Yu QM, Yu CD, Ling ZQ. Elevated circulating CD19+ lymphocytes predict survival advantage in patients with gastric cancer. Asian Pac J Cancer Prev. 2012;13(5):2219–2224. doi:10.7314/APJCP.2012.13.5.221922901197
   PubMedGoogle Scholar
• Gerloni M, Zanetti M. CD4 T cells in tumor immunity. Springer Semin Immunopathol. 2005;27(1):37–48. doi:10.1007/s00281-004-0193-z15965712
   PubMed Web of Science ®Google Scholar
• Liu L, Yao J, Ding Q, Cao R, Wang J, Huang S. [CD4+CD25high regulatory cells in peripheral blood of nasopharyngeal carcinoma]. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2005;19(20):929–931. Chinese.16398048
   PubMedGoogle Scholar
• Péron J, Cropet C, Tredan O, et al. CD4 lymphopenia to identify end-of-life metastatic cancer patients. Eur J Cancer. 2013;49(5):1080–1089. doi:10.1016/j.ejca.2012.11.00323246297
   PubMed Web of Science ®Google Scholar
• Trédan O, Manuel M, Clapisson G, et al. Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome. Eur J Cancer. 2013;49(7):1673–1682. doi:10.1016/j.ejca.2012.11.02823265706
   PubMed Web of Science ®Google Scholar
• Mao YP, Tang LL, Chen L, et al. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy. Chin J Cancer. 2016;35(1):103. doi:10.1186/s40880-016-0167-228031050
   PubMedGoogle Scholar
• Tian YM, Liu MZ, Zeng L, et al. Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Head Neck-J Sci Spec. 2019;41(5):1246–1252. doi:10.1002/hed.25545
   PubMed Web of Science ®Google Scholar
• Sage EK, Schmid TE, Sedelmayr M, et al. Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients. Radiother Oncol. 2016;118(1):176–180. doi:10.1016/j.radonc.2015.11.01626683801
   PubMed Web of Science ®Google Scholar
• Lv Y, Song M, Tian X, Yv X, Liang N, Zhang J. Impact of radiotherapy on circulating lymphocyte subsets in patients with esophageal cancer. Medicine. 2020;99(36):e20993. doi:10.1097/MD.000000000002099332898991
   PubMed Web of Science ®Google Scholar
• Cesaire M, Le Mauff B, Rambeau A, Toutirais O, Thariat J. [Mechanisms of radiation-induced lymphopenia and therapeutic impact]. Bull Cancer. 2020;107(7–8):813–822. doi:10.1016/j.bulcan.2020.04.009. Chinese.32451070
   PubMed Web of Science ®Google Scholar
• Liu LT, Chen QY, Tang LQ, et al. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients. Cancer Res Treat. 2018;50(1):19–29.28392551
   PubMed Web of Science ®Google Scholar